埃利斯波特
表位
T细胞受体
免疫学
T细胞
免疫疗法
抗原
生物
细胞毒性T细胞
外周血单个核细胞
人类白细胞抗原
分子生物学
免疫系统
体外
生物化学
作者
Jinyang Zeng,Jan Müller‐Berghaus,Xuan Duc Nguyen,Harald Klüter,Hiltrud Schönhaber,Mingxia Song,Nicole Schwinn,Dirk Schadendorf,Sergij Goerdt,Stefan B. Eichmüller,Edgar Dippel
摘要
The clonotypic T-cell receptor (TCR) is a potential target antigen for specific immunotherapy of cutaneous T-cell lymphoma (CTCL). We identified T-cell epitopes from the rearranged TCR beta chain of the malignant T-cell population by the "reverse immunology" approach. Peptide-specific T-cell lines were generated against predicted epitopes and tested for the recognition of tumor cells and cells transfected with the full-length DNA coding for TCRV beta chain. Two peptides derived from the clonotypic TCRVbeta of a HLA-A2 positive patient could induce peptide-specific T cells from peripheral blood mononuclear cells of healthy donors and the patient as assessed by IFN-gamma ELISpot assay. Furthermore, the reactive CTLs efficiently recognized autologous Sézary tumor cells, as well as HLA-A2 positive 293 cells transfected with recombinant plasmid expressing the corresponding TCRVbeta29 protein. Similar results were obtained in a HLA-A3+ patient for TCRVbeta7-Jbeta2.7. In conclusion, our experiments show that the TCR beta chain harbors epitopes suitable as targets for specific vaccination which might be a promising approach for the specific immunotherapy of cutaneous T-cell lymphoma patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI